COMPANY

Nexalin Technology

HQ: Houston, TX source · nexalin.com ↗ · Southwest

Location: Houston, TX · source · Oct 15, 2026

Profile checked Oct 10, 2026

Keywords: Moderate to Severe Insomnia Transcranial alternating current stimulator

Timeline

Oct 8, 2026 Raise Follow-on offering: $5M (total, as published), announced Oct 8, 2026. Source: company's own press page. source ↗
Jun 22, 2026 Trial start Not phased (device or behavioral study): HALO Clarity™ Cranial Alternating Current Stimulation Therapy for Adults With Moderate-to-Severe Insomnia source ↗
May 6, 2025 Raise Follow-on offering: $5M (total, as published), announced May 6, 2025. Source: company release on GlobeNewswire. source ↗

Jul 1, 2027 (ESTIMATED) · Not phased · HALO Clarity™ Cranial Alternating Current Stimulation Therapy for Adults With Moderate-to-Severe Insomnia · NCT07659366

Estimated primary completion per ClinicalTrials.gov. Dates move.

Raised: $10.0M. Last 2 years.

Oct 8, 2026 Follow-on offering: $5M (total, as published), announced Oct 8, 2026. Source: company's own press page. source ↗
May 6, 2025 Follow-on offering: $5M (total, as published), announced May 6, 2025. Source: company release on GlobeNewswire. source ↗

Record	Title	Phase	Status	Start	Primary completion
NCT07659366	HALO Clarity™ Cranial Alternating Current Stimulation Therapy for Adults With Moderate-to-Severe Insomnia	Not phased (device or behavioral study)	Not yet recruiting	Jun 22, 2026	Jul 1, 2027 (estimated)